Form 8-K - Current report:
SEC Accession No. 0001193125-21-198645
Filing Date
2021-06-24
Accepted
2021-06-24 16:01:05
Documents
13
Period of Report
2021-06-24
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d136324d8k.htm   iXBRL 8-K 44949
2 EX-3.1 d136324dex31.htm EX-3.1 220680
  Complete submission text file 0001193125-21-198645.txt   437938

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zlab-20210624.xsd EX-101.SCH 2873
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zlab-20210624_lab.xml EX-101.LAB 19590
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zlab-20210624_pre.xml EX-101.PRE 12278
6 EXTRACTED XBRL INSTANCE DOCUMENT d136324d8k_htm.xml XML 3768
Mailing Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210
Business Address 4560 JINKE ROAD BLDG. 1, 4F, PUDONG SHANGHAI F4 201210 862161632588
Zai Lab Ltd (Filer) CIK: 0001704292 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38205 | Film No.: 211042836
SIC: 2834 Pharmaceutical Preparations